HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
+15.63%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$1.17B
AUM Growth
+$1.17B
(+83%)
Cap. Flow
+$340M
Cap. Flow
% of AUM
28.99%
Top 10 Holdings %
Top 10 Hldgs %
95.04%
Holding
22
New
4
Increased
3
Reduced
9
Closed
3
Top Buys
| 1 |
Royalty Pharma
RPRX
|
$713M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$49.7M |
| 3 |
Pliant Therapeutics
PLRX
|
$18.3M |
| 4 |
Generation Bio
GBIO
|
$10.6M |
| 5 |
Uber
UBER
|
$9.56M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$255M |
| 2 |
Palo Alto Networks
PANW
|
$193M |
| 3 |
PING
Ping Identity Holding Corp.
PING
|
$8.11M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$3.02M |
| 5 |
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
|
$1.34M |
Sector Composition
| 1 | Healthcare | 67.47% |
| 2 | Technology | 14.96% |
| 3 | Communication Services | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.6B
| $713M | 60.83% |
+14,690,780
| New | +$713M |
|
|
2
Uber
UBER
$196B
| $96.7M | 8.25% |
3,112,186
+307,569
| +11% | +$9.56M |
|
|
3
Alphabet (Google) Class A
GOOGL
$2.57T
| $89.5M | 7.64% |
63,148
+35,079
| +125% | +$49.7M |
|
|
4
Palo Alto Networks
PANW
$127B
| $78.7M | 6.71% |
342,612
-839,371
| -71% | -$193M |
|
|
5
Meta Platforms (Facebook)
META
$1.86T
| $38.6M | 3.29% |
169,783
-1,121,759
| -87% | -$255M |
|
6
SPDR Gold Trust
GLD
$107B
| $22.2M | 1.89% |
132,372
-6,575
| -5% | -$1.1M |
|
7
Revolution Medicines
RVMD
$7.1B
| $21.2M | 1.81% |
670,382
| – | – |
|
|
8
iShares Core S&P 500 ETF
IVV
$662B
| $19.7M | 1.68% |
63,763
-9,743
| -13% | -$3.02M |
|
|
9
Pliant Therapeutics
PLRX
$101M
| $18.3M | 1.56% |
+562,379
| New | +$18.3M |
|
10
Invesco QQQ Trust
QQQ
$364B
| $16.3M | 1.39% |
65,673
+1,382
| +2% | +$342K |
|
|
NCNA
11
NuCana
NCNA
$6.09M
| $15.6M | 1.33% |
2,888,311
-22,800
| -0.8% | -$123K |
|
|
12
Generation Bio
GBIO
$40.4M
| $10.6M | 0.91% |
+506,273
| New | +$10.6M |
|
13
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $9.03M | 0.77% |
232,738
-28,653
| -11% | -$1.11M |
|
14
Fulcrum Therapeutics
FULC
$351M
| $7.51M | 0.64% |
410,714
| – | – |
|
15
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $3.96M | 0.34% |
22,266
-3,224
| -13% | -$573K |
|
16
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $3.62M | 0.31% |
52,998
-5,993
| -10% | -$409K |
|
17
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $3.1M | 0.26% |
78,199
-11,936
| -13% | -$473K |
|
18
Dianthus Therapeutics
DNTH
$759M
| $2.5M | 0.21% |
332,610
| – | – |
|
19
BioNTech
BNTX
$24B
| $2.13M | 0.18% |
+31,869
| New | +$2.13M |
|
20
Vanguard Dividend Appreciation ETF
VIG
$95.4B
| – | – |
-2,858
| Closed | -$295K |
|
|
PING
21
DELISTED
Ping Identity Holding Corp.
PING
| – | – |
-405,086
| Closed | -$8.11M |
|
|
NTGN
22
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| – | – |
-505,871
| Closed | -$1.34M |
|